Description
TERMINATION FOR THE GOVERNMENT'S CONVENIENCE, NATIONAL CONTRACT 36E79722D0026 IS HEREBY TERMINATED, EFFECTIVE 12/14/2023.
Base award description: DHA/EPA SUPPLEMENTS FISH OIL 1000MG (500MG DHA/EPA) CAP,ORAL
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-08-02+$0= $0
- Mod P000012023-12-15+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-08-02 | +$0 | $0 | DHA/EPA SUPPLEMENTS FISH OIL 1000MG (500MG DHA/EPA) CAP,ORAL |
| Mod P00001· TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL) | 2023-12-15 | +$0 | $0 | TERMINATION FOR THE GOVERNMENT'S CONVENIENCE, NATIONAL CONTRACT 36E79722D0026 IS HEREBY TERMINATED, EFFECTIVE… |
Related awards · 10
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ZCA9ZAN3VYV6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77025P0122 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $142,720 | FY2025 |
| 36F79722D0086 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| 36C77022P0220 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $77,600 | FY2022 |
| 36C77022P0183 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $73,817 | FY2022 |
| 36C26021P1047 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 3805 · EARTH MOVING AND EXCAVATING EQUIPMENT | $82,199 | FY2021 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79723D0026_3600 · retrieved 2026-09-26.